Expression and biological activity of two recombinant polypeptides related to subunit 1 of the interferon-a receptor

Abstract

Abnormal production of interferon alpha (IFN-=) has been found in certain autoimmune diseases and can be also observed after prolonged therapy with IFN-=. IFN-= can contribute to the pathogenesis of allograft rejection in bone marrow transplants. Therefore, the development of IFN-= inhibitors as a soluble receptor protein may be valuable for the therapeutic control of these diseases. We have expressed two polypeptides encoding amino acids 93-260 (P1) and 261-410 (P2) of the extracellular domain of subunit 1 of the interferon-= receptor (IFNAR 1-EC) in E. coli. The activities of the recombinant polypeptides and of their respective antibodies were evaluated using antiproliferative and antiviral assays. Expression of P1 and P2 polypeptides was achieved by transformation of cloned plasmid pRSET A into E. coli BL21(DE3)pLysS and by IPTG induction. P1 and P2 were purified by serial sonication steps and by gel filtration chromatography with 8 M urea and refolded by dialysis. Under reducing SDS-PAGE conditions, the molecular weight of P1 and P2 was 22 and 17 kDa, respectively. Polyclonal anti-P1 and anti-P2 antibodies were produced in mice. P1 and P2 and their respective polyclonal antibodies were able to block the antiproliferative activity of 6.25 nM IFN-=B on Daudi cells, but did not block IFN-=B activity at higher concentrations (>6.25 nM). On the other hand, the polypeptides and their respective antibodies did not inhibit the antiviral activity of IFN-=B on Hep 2/c cells challenged with encephalomyocarditis virus. Correspondence

Antiviral activities of the soluble extracellular domains of type I interferon receptors

“…Soluble receptor proteins prepared in E. coli (31,48,49) and yeast (50,51), and representing either portions of or the entire extracellular domains of huIFNAR1 (47,49), huIFNAR2 (31,50), and murine IFNAR2 (51), have been studied primarily as potential antagonists of type I IFN action. Nguyen et al (48) reported that the GST-fusion protein of huIFNAR1 extracellular domain inhibited the AV and antiproliferative activities of huIFN-␣1 and competed with the cell surface receptor for binding the IFN.…”